We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Seeks Input from Drugmakers on Swiftness of Labeling Changes
FDA Seeks Input from Drugmakers on Swiftness of Labeling Changes
December 30, 2011
The FDA may issue draft guidance on required postmarket safety labeling changes in the near future and is seeking drugmaker input on a reasonable timeframe to make such changes in print materials.